Harneet Arora1, Rebecca J Willcocks1, Donovan J Lott1, Ann T Harrington2, Claudia R Senesac1, Kirsten L Zilke3, Michael J Daniels4, Dandan Xu5, Gihan I Tennekoon2, Erika L Finanger3, Barry S Russman3, Richard S Finkel6, William T Triplett1, Barry J Byrne7, Glenn A Walter8, H Lee Sweeney9, Krista Vandenborne1. 1. Department of Physical Therapy, University of Florida, Box 100154, UFHSC, Gainesville, Florida, 32610, USA. 2. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 3. Oregon Health & Science University, Portland, Oregon, USA. 4. Department of Statistics, University of Florida, Gainesville, Florida, USA. 5. Department of Statistics & Data Sciences, The University of Texas at Austin, Austin, Texas, USA. 6. Nemours Children's Hospital, Orlando, Florida, USA. 7. Department of Pediatrics and Molecular Genetics and Microbiology, Powell Gene Therapy Center, University of Florida, Gainesville, Florida, USA. 8. Department of Physiology and Functional Genomics, University of Florida, Gainesville, Florida, USA. 9. Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, USA.
Abstract
INTRODUCTION: Tests of ambulatory function are common clinical trial endpoints in Duchenne muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large data set that can describe the contemporary natural history of DMD in 5-12.9-year-olds. METHODS: Ninety-two corticosteroid-treated boys with DMD and 45 controls participated in this longitudinal study. Participants performed the 6-minute walk test (6MWT) and timed function tests (TFT: 10-m walk/run, climbing 4 stairs, supine to stand). RESULTS: Boys with DMD had impaired functional performance even at 5-6.9 years old. Boys older than 7 had significant declines in function over 1 year for 10-m walk/run and 6MWT. Eighty percent of participants could perform all functional tests at 9 years old. TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds. DISCUSSION: This study provides insight into the contemporary natural history of key functional endpoints in DMD. Muscle Nerve 58: 631-638, 2018.
INTRODUCTION: Tests of ambulatory function are common clinical trial endpoints in Duchenne muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large data set that can describe the contemporary natural history of DMD in 5-12.9-year-olds. METHODS: Ninety-two corticosteroid-treated boys with DMD and 45 controls participated in this longitudinal study. Participants performed the 6-minute walk test (6MWT) and timed function tests (TFT: 10-m walk/run, climbing 4 stairs, supine to stand). RESULTS:Boys with DMD had impaired functional performance even at 5-6.9 years old. Boys older than 7 had significant declines in function over 1 year for 10-m walk/run and 6MWT. Eighty percent of participants could perform all functional tests at 9 years old. TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds. DISCUSSION: This study provides insight into the contemporary natural history of key functional endpoints in DMD. Muscle Nerve 58: 631-638, 2018.
Authors: Jerry R Mendell; Chris Shilling; Nancy D Leslie; Kevin M Flanigan; Roula al-Dahhak; Julie Gastier-Foster; Kelley Kneile; Diane M Dunn; Brett Duval; Alexander Aoyagi; Cindy Hamil; Maha Mahmoud; Kandice Roush; Lauren Bird; Chelsea Rankin; Heather Lilly; Natalie Street; Ram Chandrasekar; Robert B Weiss Journal: Ann Neurol Date: 2012-03 Impact factor: 10.422
Authors: Ishu Arpan; Rebecca J Willcocks; Sean C Forbes; Richard S Finkel; Donovan J Lott; William D Rooney; William T Triplett; Claudia R Senesac; Michael J Daniels; Barry J Byrne; Erika L Finanger; Barry S Russman; Dah-Jyuu Wang; Gihan I Tennekoon; Glenn A Walter; H L Sweeney; Krista Vandenborne Journal: Neurology Date: 2014-08-06 Impact factor: 9.910
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: Katharine Bushby; Richard Finkel; Brenda Wong; Richard Barohn; Craig Campbell; Giacomo P Comi; Anne M Connolly; John W Day; Kevin M Flanigan; Nathalie Goemans; Kristi J Jones; Eugenio Mercuri; Ros Quinlivan; James B Renfroe; Barry Russman; Monique M Ryan; Mar Tulinius; Thomas Voit; Steven A Moore; H Lee Sweeney; Richard T Abresch; Kim L Coleman; Michelle Eagle; Julaine Florence; Eduard Gappmaier; Allan M Glanzman; Erik Henricson; Jay Barth; Gary L Elfring; Allen Reha; Robert J Spiegel; Michael W O'donnell; Stuart W Peltz; Craig M Mcdonald Journal: Muscle Nerve Date: 2014-10 Impact factor: 3.217
Authors: Erik Henricson; Richard Abresch; Jay J Han; Alina Nicorici; Erica Goude Keller; Evan de Bie; Craig M McDonald Journal: PLoS Curr Date: 2013-07-08
Authors: Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart W Peltz Journal: Muscle Nerve Date: 2013-07-17 Impact factor: 3.217
Authors: Daniela J Conrado; Jane Larkindale; Alexander Berg; Micki Hill; Jackson Burton; Keith R Abrams; Richard T Abresch; Abby Bronson; Douglass Chapman; Michael Crowther; Tina Duong; Heather Gordish-Dressman; Lutz Harnisch; Erik Henricson; Sarah Kim; Craig M McDonald; Stephan Schmidt; Camille Vong; Xiaoxing Wang; Brenda L Wong; Florence Yong; Klaus Romero Journal: J Pharmacokinet Pharmacodyn Date: 2019-05-24 Impact factor: 2.745
Authors: Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne Journal: Muscle Nerve Date: 2020-11-27 Impact factor: 3.217
Authors: Xiaonan Li; Laurie S Conklin; John van den Anker; Eric P Hoffman; Paula R Clemens; William J Jusko Journal: J Clin Pharmacol Date: 2020-05-20 Impact factor: 3.126
Authors: Rebecca J Willcocks; Alison M Barnard; Ryan J Wortman; Claudia R Senesac; Donovan J Lott; Ann T Harrington; Kirsten L Zilke; Sean C Forbes; William D Rooney; Dah-Jyuu Wang; Erika L Finanger; Gihan I Tennekoon; Michael J Daniels; William T Triplett; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: J Neuromuscul Dis Date: 2022
Authors: Alison M Barnard; Rebecca J Willcocks; William T Triplett; Sean C Forbes; Michael J Daniels; Saptarshi Chakraborty; Donovan J Lott; Claudia R Senesac; Erika L Finanger; Ann T Harrington; Gihan Tennekoon; Harneet Arora; Dah-Jyuu Wang; H Lee Sweeney; William D Rooney; Glenn A Walter; Krista Vandenborne Journal: Neurology Date: 2020-02-05 Impact factor: 9.910
Authors: Thom T J Veeger; Erik W van Zwet; Diaa Al Mohamad; Karin J Naarding; Nienke M van de Velde; Melissa T Hooijmans; Andrew G Webb; Erik H Niks; Jurriaan H de Groot; Hermien E Kan Journal: Muscle Nerve Date: 2021-08-25 Impact factor: 3.852